Johnson & Johnson agrees to $5.5 billion settlement for baby powder cancer claims

Johnson & Johnson will pay $5.5 billion to settle ovarian cancer claims. This landmark settlement covers nearly all remaining talc lawsuits against the company. The deal requires acceptance from ninety-five percent of claimants for finalization. Johnson & Johnson stated the claims were meritless and sought closure. The company has long denied its talc products caused cancer.

Raccontata dahealio.comchannelnewsasia.comaljazeera.comeconomictimes.indiatimes.comrappler.comrnz.co.nznewsbytesapp.comthehindu.comtheguardian.comabc.net.augulfnews.commalaymail.com+6 altre